CORMORANT ASSET MANAGEMENT, LP Intra-Cellular Therapies, Inc. Transaction History

CORMORANT ASSET MANAGEMENT, LP portfolio value:

$0
portfolio value

CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -275K shares -15.69M $46.53 0
Q2 2022 share Increase +83.33% 125K shares 6.51M $57.08 275K
Q1 2022 share Increase 0.00% 150K shares 9.17M $61.19 150K